Loading news...
The Chemours Company (NYSE: CC - Get Free Report) saw some unusual options trading activity on Friday. Stock investors purchased 10,642 call options on the company. This is an increase of 182% compared to the typical volume of 3,771 call options. Chemours Stock Performance Shares of CC stock opened at $17.60 on Friday. Chemours has a
WILMINGTON, Del., March 12, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced it completed its previously announced private offering of $700,000,000 in aggregate principal amount of 7.875% senior unsecured notes due 2034 (the "Notes") that was exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act").
NEW YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Dynamic Technology Lab Private Ltd acquired a new stake in shares of The Chemours Company (NYSE: CC) in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 28,039 shares of the specialty chemicals company's stock, valued at approximately $444,000. Other hedge funds also
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
CC prices $700M of 7.875% senior notes due 2034, upsizing the deal to refinance 2027 and 2028 debt and reshape its debt profile.
Shares of The Chemours Company (NYSE: CC - Get Free Report) have received a consensus rating of "Hold" from the twelve analysts that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating on the company.
WILMINGTON, Del., Feb. 26, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced the pricing of its previously announced private offering of $700,000,000 aggregate principal amount of new 7.875% senior notes due 2034 (the "Notes").
NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
WILMINGTON, Del., Feb. 26, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that it intends to offer $600,000,000 aggregate principal amount of new senior notes due 2034 (the "Notes"), subject to market and other conditions.
Successful qualification of Opteon™ fluid in 2CRSi server sparks broader collaboration to drive innovation in new and existing technologies across respective portfolios WILMINGTON, Del. and STRASBOURG, France, Feb. 24, 2026 /PRNewswire/ -- The Chemours Company (NYSE: CC), a global chemistry company, and 2CRSi (ISIN code: FR0013341781), a pioneer in high-performance, eco-responsible server technology, today announced a Joint Development Agreement (JDA)1 following the successful qualification of Chemours' Opteon™ two-phase immersion cooling fluid in current-generation 2CRSi servers.
Chemours Company is downgraded to "Hold" after a sharp rally, with shares now fairly valued around $18. CC's TSS segment benefits from Opteon adoption and future data center demand, but other units face ongoing macro headwinds. Leverage remains elevated at 4.7x; asset sales and cash flow should reduce leverage to 4x by year-end, but further progress will be slow.
Advanced Performance Materials business president to help guide SEMI's efforts supporting North America's semiconductor innovation and supply chain resilience WILMINGTON, Del., Feb. 23, 2026 /PRNewswire/ --The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, today announced that Gerardo Familiar, President of the company's APM business, has been appointed to the SEMI North America Advisory Board (NAAB).
CC posts a wider y/y loss in Q4 as sales dip 2%, but the bottom line beats estimates and Thermal & Specialized Solutions surges on strong refrigerant pricing.
Chemours met revenue expectations but missed profit expectations in the fourth quarter. The stock had roughly doubled since late November, so a pullback on anything less than perfect is no surprise.
The Chemours Company (CC) Q4 2025 Earnings Call Transcript
Stock futures are lower after fourth-quarter GDP badly missed estimates
Chemours reports quarterly earnings per share of 5 cents, 2 cents lighter than Wall Street expectations.